Stand Up And Be Counted
Completely agree with @dereklowe.bsky.social This is not a time to keep our heads down and hope the storm passes... www.science.org/content/blog...
14.02.2025 15:25 — 👍 1 🔁 0 💬 0 📌 0
Where am I?
12.01.2025 22:28 — 👍 2 🔁 0 💬 0 📌 0
A platform for life sciences. Publications, research protocols, news, events, jobs and more. Sign up at https://www.lifescience.net.
Mobilizing the fight for science and democracy, because Science is for everyone 🧪🌎
The hub for science activism!
Learn more ⬇️
http://linktr.ee/standupforscience
Californian biotechie | Bio(+)tech(+)engineering R&D | PhD + MBA | C{X}O | BOD | USA +EU +UK | Atheneos Ventures | Renexxion | Helios Orion | +4 more | @Stanford | Post+RP+QP = mine
I'm focused on the prevention of Alzheimer's disease in Down syndrome (DS-AD). I'm a younger sibling of an adult with Down syndrome, and I'll be keeping my feed up-to-date with the latest research on DS-AD that I find interesting.
CRISPR Chief Technology Officer
Alum: @HuidaGene @ExcisionBio @CRISPRTx @GeorgiaTech @SangamoTx @UIowa @UCSF @MIT Posts = own.
Functional genomics @ Broad Institute. Screen all the things!
Drug developer | Co-founder of Gate Bio | Fmr Big Pharma | Inventing small molecule medicines | Artist | Polymath
Lead Editor: #CRBIOTECH & #ExplorDHT | Chair of Pharmacology at DPU | Prof of IGAB-PAS | Leader: #DHPSP & #INPST | Author of #HealthHacksThatWork
🔗Web: https://digitalpatientsafety.com/atanas-g-atanasov/
Synthetic biology, protein engineering, and the future of biotechnology.
Founder of GRO Biosciences.
Neuroscientist | Biomedical Engineer | PhD Candidate at Columbia University
My research focuses on neural circuit changes, working memory deficits, and adult neurogenesis, using advanced imaging techniques like confocal and light-sheet microscopy
Boards @MIT @VoyagerTx @IAmBiotech @BloomScience Emm; former CEO InCarda; alum @MITChemE @Penn; #BLM #LatinX🇵🇷🌈🌊💙 Longtime biotech geek, board member and entrepreneur. #BioSky #BiotechCEOSisterhood
BioCentury is the trusted intelligence and networking platform that helps biopharma leaders and investors see what’s next, shape transformative medicines and make the decisions that matter.
Welcome to the official Bluesky account for the New England Journal of Medicine. Follow for high-quality, peer-reviewed research and clinical content from the world’s leading medical journal, online at NEJM.org.
Follow @ai.nejm.org for medical AI content.
Cell aims to publish the most exciting and provocative research in biology. Posts by Scientific Editors on the Cell editorial team. See the latest papers at https://www.cell.com/cell/
Nature Genetics is a monthly journal publishing high impact research in genetics and genomics. Part of @natureportfolio.bsky.social
Repost/like=interesting/relevant, not necessarily endorsement.
Founding CEO of Alnylam Pharmaceuticals. RNAi therapeutics pioneer.
CEO and Principal of JMM Innovations, LLC. Committed to advancing biomedical innovation to patients.
ALS/MND Researcher @ UMCU | Clinical Trial Methodology, Outcomes & Statistics | Part-time cyclist 🚴♂️
Biotech optimist and enthusiast. Dreamer, thinker, and loudmouth. Opinions are my own and likely not well composed. www.isaacstoner.com
